W. Fraser Symmans

5 ta ish

The University of Texas MD Anderson Cancer Center

1. Gene Expression Profiles Predict Complete Pathologic Response to Neoadjuvant Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy in Breast Cancer

   Mark Ayers, W. Fraser Symmans, James Stec +15

   Maqola20043 iqtibos

   ABIABI:AkademIndex/2026.other.434439

2. Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy

   Roman Rouzier, Charles M. Perou, W. Fraser Symmans +13

   Maqola20053 iqtibos

   ABIABI:AkademIndex/2026.other.434441

3. Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

   Cornelia Liedtke, Chafika Mazouni, Kenneth R. Hess +10

   Maqola20233 iqtibos

   ABIABI:AkademIndex/2026.other.434446

4. Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

   Kimberly H. Allison, M. Elizabeth H. Hammond, Mitch Dowsett +17

   Maqola20203 iqtibos

   ABIABI:AkademIndex/2026.other.833904

5. Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1

   Jong‐Ho Cha, Wenhao Yang, Weiya Xia +25

   MaqolaOAOchiq kirish20182 iqtibos

   ABIABI:AkademIndex/2026.other.082834